Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Venrock Healthcare Capital Partners III, L.P.. Insider active across 2 companies, notably KalVista Pharmaceuticals, Inc.. Aggregated, 15 disclosures have been logged. Breakdown: 14 buys · 1 sell. Total volume traded: €9.2m. History available since 27 December 2023. The latest transaction was filed on 25 March 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Venrock Healthcare Capital Partners III, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
41,514 shares@ US$11.976.8% of flowCommon StockSEC:0001209191-23-060015:0
Canonical exit: 26 Mar 2024 (T+90)
15 of 15 declarations
About Venrock Healthcare Capital Partners III, L.P.
Venrock Healthcare Capital Partners III, L.P. is a declarant with 15 filings in total. Across the 15 sampled filings, the transactions run from 2023-12-29 to 2026-03-27, with buy volume of EUR 6659880 and sell volume of EUR 2546366, mainly in KalVista Pharmaceuticals, Inc. and Oruka Therapeutics, Inc.